secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2022-10-04T23:59:59+00:00
Accession:  0001104659-22-105831
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Anzu Special Acquisition Corp I expands board to five, appoints Hirsch as CFO and Dewbrey as director
--------------------------------------------------------------------------------

- Board increased from 3 to 5 directors; Hirsch and Dewbrey appointed as directors effective Oct 1, 2022.
- Hirsch named CFO and Corporate Secretary; previously COO/CFO of Cascade Acquisition Corp.
- Dewbrey determined independent, appointed to Audit, Compensation, Nominating committees and chair of Compensation.
- Sponsor transferred 25,000 Class B shares to each new director.
- Indemnification agreements entered with Hirsch and Dewbrey.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000110465922105831/0001104659-22-105831-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000110465922105831/tm2227306d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-105831

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer